N-803 and Gemcitabine

Drug identity checked against registry records

Also recorded as Gemcitabine; Gemzar; N-803

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder CancerNCT06829823IBRXPhase 2Not yet recruiting2026-11Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.